DIS-CHEM PHARMACIES LIMITED - Dealings in Securities

Dealings in Securities

Dis-Chem Pharmacies Limited
(Incorporated in the Republic of South Africa)
(Registration number 2005/009766/06)
JSE share code: DCP
ISIN: ZAE000227831
("Dis-Chem" or the "Company")

DEALINGS IN SECURITIES

Shareholders of Dis-Chem are advised of the following dealings in the Company's securities due to the exercise of the Share
Appreciation Rights (SARs).

In compliance with sections 3.63 to 3.74 of the Listings Requirements of the JSE Limited, the following information is disclosed:

Name of prescribed officer:                      Mr Kevin Sterling
Nature and extent of interest:                   Direct beneficial
Class of securities:                             Ordinary shares

Nature of transaction:                           Off-market exercise of 65 596 SARs previously awarded in terms of the SARs Plan
                                                 following vesting
Total number of shares:                          12 397
Exercise price per share:                        R35.60
Total value of transaction:                      R441 333.20

Nature of transaction:                           On-market sale of ordinary shares
Number of shares traded:                         12 397
Price per share:                                 R35.60
Total value of transaction:                      R441 333.20

Date of transactions:                            26 July 2024
Clerance to deal obtained:                       Yes

Midrand
29 July 2024

Company Secretary
Nikki Lumley

Sponsor
The Standard Bank of South Africa Limited

Date: 29-07-2024 02:10:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.